kite pharma Christi Shaw taken on by Gilead as Kite Pharma's new CEO By www.pharmafile.com Published On :: Thu, 25 Jul 2019 14:43:03 +0000 Lilly veteran Christi Shaw has joined Kite Pharma as the company’s new CEO. Shaw comes to Gilead’s cancer immunotherapy firm, Kite Pharma, from rival US firm Eli Lilly, where she acted as a senior vice president and also as president of Lilly’s immunology, pain and neuroscience unit, Lilly Bio Medicines. read more Full Article Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
